|
|
Article: Successful European Introduction of First ADM Product to Include SCOLR's CDT Technology; Novasoy Daily Dose Presented to ADM's European Corporate Partners.
- Article from:
- Business Wire
- Article date:
- October 9, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
REDMOND, Wash.--(BUSINESS WIRE)--Oct. 9, 2002
SCOLR, Inc. (OTCBB:SCLL) commented today on the announcement made previously by its global marketing partner, Archer Daniels Midland (NYSE:ADM), that ADM had made its first commercial presentation of Novasoy(R) Daily Dose(TM), the first ADM product in a planned series to include SCOLR's patented CDT(TM) drug delivery technology. The European commercial presentation of Novasoy(R) Daily Dose was made in Paris, France, at the HIE Exhibit in September. SCOLR anticipates the U.S. introduction of Novasoy(R) Daily Dose to corporate partners by ADM this quarter with sales to ...